Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis Review

Document Sample
Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					           Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME364FSA                                                                                             Publication Date: JUN 2013

          3240 Whipple Road                                  Phone              +1 510 6756500                  Revenue          156.6 (million USD)
          Union City, CA                                     Fax                +1 510 4416150                  Net Profit       27.46 (million USD)
          94587                                              Website            www.abaxis.com                  Employees        535
          United States                                      Exchange           ABAX [NASDAQ]                   Industry         Medical Equipment

       Company Overview
       Abaxis, Inc. (Abaxis) is a medical device company. It undertakes the development, production and marketing of portable blood
       analysis systems for human and veterinary patient-care setting. The portable blood systems are used to measure rapid blood
       constituents in any human and veterinary patient care setting. Abaxis classifies its products in two divisions, namely, medical and
       veterinary diagnostics. The company carries out its European operations through its wholly owned subsidiary, Abaxis Europe
       GmbH. It distributes its products in the US through direct sales force and worldwide other than the US through a network of
       distributors. Abaxis is headquartered in California, the US.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Abaxis, Inc., SWOT Analysis
         Clinton H. Severson                 Chairman                                 Strengths                              Weaknesses
         Prithipal Singh, Ph.D.              Director
                                                                                      Expanded Abaxis Veterinary             Single Manufacturing Facility
         Richard J. Bastiani Ph.D.           Director                                 Reference Laboratories
                                                                                                                             Reliance on Distributors
         Henk J. Evenhuis                    Director
                                                                                      Strategic Agreements
         Vernon E. Altman                    Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Growth in Emerging Economies Stringent Regulations
         Abaxis, Inc.
                                                                                      Product Innovation                     Changes in Reimbursement
        Share Price (USD) as on 21-Jun-                                46.02                                                 Regulations
        2013
        EPS (USD)                                                        1.23
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million USD)                                       1,018         GlobalData

        Enterprise Value (million USD)                                   964
        Shares Outstanding (million)                                       22
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Apr 25, 2013         Abaxis Reports Revenue Of $186m In Fiscal
                                                                                                           2013
                                                                                      Jan 31, 2013         Abaxis Reports Revenue Of $49.8m In Q3
                                                                                                           Fiscal 2013
                                                                                      Oct 23, 2012         Abaxis Reports Revenue Of $44.3m In Q2
                                                                                                           Fiscal 2013
                                                                                      Sep 26, 2012         Abaxis Announces Settlement             Of    Patent
                                                                                                           Litigation With Cepheid
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis                                                                      Reference Code: GDME364FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Abaxis, Inc. - Key Facts ...................................................................................................................................................................... 5
       Abaxis, Inc. - Key Employees ............................................................................................................................................................. 6
       Abaxis, Inc. - Key Employee Biographies ........................................................................................................................................... 7
       Abaxis, Inc. - Key Operational Employees ......................................................................................................................................... 8
       Abaxis, Inc. - Major Products and Services ........................................................................................................................................ 9
       Abaxis, Inc. - History ........................................................................................................................................................................ 11
       Abaxis, Inc. - Company Statement ................................................................................................................................................... 14
       Abaxis, Inc. - Locations And Subsidiaries ........................................................................................................................................ 16
          Head Office ................................................................................................................................................................................... 16
          Other Locations & Subsidiaries ..................................................................................................................................................... 16
       Section 2 – Company Analysis ......................................................................................................................................................... 17
       Abaxis, Inc. - Business Description .................................................................................................................................................. 17
       Abaxis, Inc. - Corporate Strategy ..................................................................................................................................................... 18
       Abaxis, Inc. - SWOT Analysis........................................................................................................................................................... 19
          SWOT Analysis - Overview........................................................................................................................................................... 19
          Abaxis, Inc. - Strengths ................................................................................................................................................................. 19
             Strength - Expanded Abaxis Veterinary Reference Laboratories .............................................................................................. 19
             Strength - Strategic Agreements ............................................................................................................................................... 19
             Strength - Strong Product Offerings .......................................................................................................................................... 19
             Strength - Proprietary Technology - The Orbos Process........................................................................................................... 20
          Abaxis, Inc. - Weaknesses............................................................................................................................................................ 20
             Weakness - Single Manufacturing Facility................................................................................................................................. 20
             Weakness - Reliance on Distributors ........................................................................................................................................ 20
             Weakness - Over-dependence on the North American Market ................................................................................................. 20
          Abaxis, Inc. - Opportunities ........................................................................................................................................................... 21
             Opportunity - Growth in Emerging Economies .......................................................................................................................... 21
             Opportunity - Product Innovation ............................................................................................................................................... 21
             Opportunity - Growing In Vitro Diagnostics Market ................................................................................................................... 21
             Opportunity - Strategic Initiatives .............................................................................................................................................. 21
          Abaxis, Inc. - Threats .................................................................................................................................................................... 22
             Threat - Stringent Regulations .................................................................................................................................................. 22
             Threat - Changes in Reimbursement Regulations .................................................................................................................... 22
             Threat - Changing Diagnostic Market Conditions ...................................................................................................................... 22
       Abaxis, Inc. - Key Competitors ......................................................................................................................................................... 23
       Section 3 – Company Financial Ratios ............................................................................................................................................. 24
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 24
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 24
       Performance Chart ........................................................................................................................................................................... 26
       Financial Performance...................................................................................................................................................................... 26
       Financial Ratios - Interim Ratios....................................................................................................................................................... 27
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 28


Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis                                                                                                       Reference Code: GDME364FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 29
          Abaxis, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 ........................................................................................... 29
          Abaxis, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013........................................................................................... 30
       Abaxis, Inc., Recent Deals Summary ............................................................................................................................................... 31
       Section 5 – Company’s Recent Developments ................................................................................................................................ 32
          Abaxis, Inc., Recent Developments .............................................................................................................................................. 32
             Apr 25, 2013: Abaxis Reports Revenue Of $186m In Fiscal 2013 ............................................................................................ 32
             Jan 31, 2013: Abaxis Reports Revenue Of $49.8m In Q3 Fiscal 2013 ..................................................................................... 32
             Oct 23, 2012: Abaxis Reports Revenue Of $44.3m In Q2 Fiscal 2013 ...............................................................
				
DOCUMENT INFO
Description: Abaxis, Inc. (ABAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Abaxis, Inc. (Abaxis) is a medical device company. It undertakes the development, production and market
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.